Dr. Cobb is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1315 Golden Valley Circle
Billings, MT 59102Phone+1 406-670-3721Fax+1 406-238-6280
Education & Training
San Antonio Uniformed Services Health Education ConsortiumFellowship, Hematology and Medical Oncology, 1988 - 1991
Fitzsimons Army Medical CenterResidency, Internal Medicine, 1985 - 1988
Tulane University School of MedicineClass of 1985
Certifications & Licensure
MT State Medical License 1995 - 2025
WY State Medical License 1995 - 2025
GA State Medical License 1992 - 1995
LA State Medical License 1985 - 1991- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
Publications & Presentations
PubMed
- 21 citationsOvercoming Barriers to Referral for Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.Marc S Hoffmann, Bradley D Hunter, Patrick W Cobb, Juan C Varela, Javier Munoz
Transplantation and Cellular Therapy. 2023-07-01 - 7 citationsEfficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product.Dietger Niederwieser, Caroline Hamm, Patrick Cobb, Mindy Mo, Cecily Forsyth
Targeted Oncology. 2020-10-01 - 15 citationsEflapegrastim, a Long-Acting Granulocyte-Colony Stimulating Factor for the Management of Chemotherapy-Induced Neutropenia: Results of a Phase III Trial.Lee S. Schwartzberg, Gajanan Bhat, Julio Antonio Peguero, Richy Agajanian, Jayaram S. Bharadwaj
The Oncologist. 2020-08-01
Press Mentions
Holy Rosary Healthcare Announces Construction of Comprehensive Cancer Center Serving Eastern MontanaJanuary 30th, 2023
Phase 2 Study of Duvelisib in Previously Treated Patients with Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (BRIO)December 12th, 2017- Initial Reactions to the Oncology Care ModelMarch 25th, 2015
Grant Support
- Montana Cancer ConsortiumNational Cancer Institute2000–2004
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
